David Agus: A new strategy on the war on cancer
Traditionally, David Agus explains, cancer treatments have had a short-sighted focus on the offending individual cells. He suggests a new, cross-disciplinary approach, using atypical drugs, computer modeling and protein analysis to treat and analyse the whole body.
ABOUT TED
TED is a small Non Profit devoted to Ideas Worth Spreading. It started in 1984 as a conference bringing together people from three worlds: Technology, Entertainment and Design. They make the best talks and performances from TED and partners available to the world, for free. These videos are released under a Creative Commons license, so they can be freely shared and reposted. Here at PLO.com I repost them for your convenience. All videos found in this section have previously appeared in the Major MindStylers section on the frontpage of my website. Enjoy.
ABOUT David Agus
“David Agus is a medical doctor and a Professor of Medicine at the University of Southern California. However, he is also the founder of a couple of game-changing medical initiatives.
In 2006, he co-founded Navigenics with Dietrich Stephan, Ph.D., to form a company that would provide people with their individual genetic information, allowing them to act on any predispositions to disease that they might have and prevent onset.
He also founded Oncology.com which was the largest cancer Internet resource and community. David’s research is focused on the application of proteomics and genomics in the study of cancer, as well as developing new therapeutic treatments for cancer.
He serves as Director of the USC Centre for Applied Molecular Medicine and the USC Westside Prostate Cancer Centre. He is also the recipient of several honours and awards, including the ‘American Cancer Society Physician Research Award’, a C’linical Scholar Award’ from the Sloan-Kettering Institute and the International Myeloma Foundation Visionary Science Award.”
The VIDEO
RELATED
1. Navigenics
